Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01507662 · ClinicalTrials.gov registry record · NA

Patient Activation After DXA Result Notification

A NA study, sponsored by Fredric D Wolinsky.

Completed
Registry status
NA
Development phase
7,749
Enrollment target

NCT01507662: Completed NA study, sponsored by Fredric D Wolinsky.

NCT01507662 is a NA study that has completed, run by Fredric D Wolinsky. The registered enrollment target is 7,749 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (452% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01507662, a NA study, has completed, sponsored by Fredric D Wolinsky.

COMPLETED
Registry status
NA
Development phase
7,749 participants
Enrollment target

Study Summary

There is growing evidence that patients undergoing bone mineral density testing (BMD) often do not take important steps to improve their bone health. The investigators will conduct a randomized-controlled trial to evaluate the impact of a novel and practical patient activation intervention (mailing patients their bone density test results) on the quality of bone-related healthcare and the cost-effectiveness of BMD testing. Equally important, the investigators intervention could easily be modified to include other patient populations and chronic diseases.

Primary Outcome

Guideline concordant was defined as those who prescribed a National Osteoporosis Foundation approved osteoporosis therapy for patients with osteoporosis (T-score of femoral neck, hip, or spine ≤-2.5 or FRAX ≥20 %), or patients with a self-reported history of low impact fracture, or patients with osteopenia (T-score between -1.0 and -2.5 at the femoral neck, hips, or lumbar spine) and a 10-year probability of a major osteoporosis-related fracture ≥20 % OR those who were not prescribed a therapy f

Interventions

  • BEHAVIORAL Bone Mineral Density Result Letter and Bone Health Brochure

Trial Details

FieldValue
Enrollment Target 7,749 participants
Start Date 2012-02
Est. Completion 2015-11
Phase NA
Fredric D Wolinsky

2 total trials

What the finished NCT01507662 record still lists

NCT01507662 is an interventional study that assigns participants to a tested intervention. Its 7,749 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (452% higher).

The record links to 0 conditions, and to 1 intervention - of which Bone Mineral Density Result Letter and Bone Health Brochure is the first listed.

NCT01507662 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01507662 about?

NCT01507662 is a clinical study titled "Patient Activation After DXA Result Notification". There is growing evidence that patients undergoing bone mineral density testing (BMD) often do not take important steps to improve their bone health. The investigators will conduct a randomized-controlled trial to evaluate the impact of a novel and practical patient activation intervention (mailing ...

What is the current status of trial NCT01507662?

This trial is currently completed. It is a NA study. The enrollment target is 7,749 participants. The study started on 2012-02. Estimated completion is 2015-11.

What interventions are being tested in trial NCT01507662?

The interventions under investigation include: Bone Mineral Density Result Letter and Bone Health Brochure (BEHAVIORAL).

Who is sponsoring clinical trial NCT01507662?

This trial is sponsored by Fredric D Wolinsky, which has 2 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01507662's enrollment target sits among peer trials

7,749 20th of 2000 higher than 1,981 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06560398 · 7,649 participants · NA

    Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)

  • NCT03848312 · 7,600 participants · Phase 3

    Preventing Alzheimer's With Cognitive Training

  • NCT00439049 · 7,500 participants

    Substance Abuse Pre-Treatment Screening Study

  • NCT04809740 · 7,500 participants · NA

    Evaluating the Implementation and Impact of Navigator-delivered ePRO System

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01507662, the US trial registry maintained by the National Library of Medicine. NCT01507662 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.